| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 408.44 | 66.8% | 24.7% |
| Total Income | 412.97 | 65.3% | 24.2% |
| Expenditure | 408.33 | 72.9% | 20.1% |
| PBT | 4.64 | 65.8% | 86.3% |
| Net Profit | 2.80 | 76.7% | 89.9% |
| OPM | 5.05% | 6.39pp | 3.29pp |
| NPM | 0.68% | 4.12pp | 4.41pp |
| EPS | 1.87 | 76.7% | 89.9% |
Agarwal Industrial Corporation Ltd Reports Q3 & 9M FY Consolidated Financial Performance with 409 Crore Revenue
16 Feb 2026 · 16 Feb, 5:02 pm
Summary
Agarwal Industrial Corporation Limited reported financial updates for Q3 & 9M FY26.
Key Highlights
- 1
rev: 3409
- 2
ebitda: 26
- 3
ebitda margin: 6.3%
- 4
pbt: 4.64
- 5
pat: 2.80
Management Comments
Unknown
The quarter witnessed temporary supply-side tightness and shipment timing adjustments driven by global geopolitical volatility. These developments impacted international trade routes and source- region availability during FY26. The moderation in performance was primarily attributable to shipment timing mismatches, extended voyage-cycle adjustments, and short-term supply constraints in key source markets. Importantly, these factors are cyclical and supply-driven in nature, and do not reflect any structural weakness in the Company’s business model. There has been no structural decline in domestic bitumen demand. Infrastructure activity remains steady, project execution continues across regions, and the underlying consumption drivers remain intact. The Company has also received strong orders from IOCL, BPCL, and HPCL, as stated in earlier announcements.
Unknown
While near-term shipment timing volatility may persist depending on global developments, domestic infrastructure demand remains stable. Management believes FY26 represents a volatility-driven transitional year rather than a period of structural weakness in the Company’s business fundamentals. As supply-side conditions ease, cargo flow and throughput are expected to realign with long-term demand fundamentals.
Informational and educational content only. Not investment advice.